Ewha Med J.  2023 Dec;46(S1):e28. 10.12771/emj.2023.e28.

Influence of the COVID-19 Pandemic on the Treatment Patterns and Outcomes of Colorectal Cancer

• Park IJ

• KMID: 2550848
• DOI: http://doi.org/10.12771/emj.2023.e28

Abstract

Over the past 3 years, the COVID-19 pandemic has posed significant challenges to the healthcare system, leading to delays in the diagnosis and treatment of various diseases due to the need for social distancing measures. Colorectal cancer has not been immune to these disruptions, and research in various countries has explored the impact of COVID-19 on the diagnosis and treatment of colorectal cancer. One notable consequence has been the postponement of colorectal cancer screenings, potentially resulting in disease progression, which can adversely affect surgical and oncological outcomes. Furthermore, the treatment approach for colorectal cancer may vary depending on the extent of disease progression and the healthcare policies implemented in response to the COVID-19 pandemic. In this systematic review, we examine treatment strategies, surgical outcomes, and oncological variables across multiple studies focusing on colorectal cancer treatment during the COVID-19 pandemic. The purpose of this analysis was to assess how medical policies enacted in response to the COVID-19 pandemic have influenced the outcomes of colorectal cancer treatment. We hope that this review will provide valuable insights and serve as a foundational resource for developing guidelines to address potential medical crises in the future.

Keyword

COVID-19; Colorectal neoplasms; General surgery; Stage; Complication

Figure

• 

  Fig. 1. Number of colonoscopies performed for screening purposes by year in South Korea.

Reference

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71(3):209–249. DOI: 10.3322/caac.21660. PMID: 33538338.

2. Kim MH, Park S, Yi N, Kang B, Park IJ. Colorectal cancer mortality trends in the era of cancer survivorship in Korea: 2000−2020. Ann Coloproctol. 2022; 38(5):343–352. DOI: 10.3393/ac.2022.00535.0076. PMID: 36353833. PMCID: PMC9650346.

3. Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial. JAMA Oncol. 2022; 8(1):e215445.

4. Park KJ. Against all odds: why surgeons need to be more aggressive in the era of the multidisciplinary team approach to colorectal cancer. Ann Coloproctol. 2022; 38(6):393–397. DOI: 10.3393/ac.2022.00822.0117. PMID: 36596299. PMCID: PMC9816559.

5. Kim YJ, Kim CH. Treatment for peritoneal metastasis of patients with colorectal cancer. Ann Coloproctol. 2021; 37(6):425–433. DOI: 10.3393/ac.2021.00920.0131. PMID: 34961304. PMCID: PMC8717073.

6. Tejedor P, Francis N, Jayne D, Hohenberger W, Khan J. Consensus statements on complete mesocolic excision for right-sided colon cancer-technical steps and training implications. Surg Endosc. 2022; 36(8):5595–5601. DOI: 10.1007/s00464-021-08395-0. PMID: 35790593. PMCID: PMC9283340.

7. Park IJ. Precision medicine for primary rectal cancer will become a reality. Ann Coloproctol. 2022; 38(4):281–282. DOI: 10.3393/ac.2022.00500.0071. PMID: 36059074. PMCID: PMC9441542.

8. Bae JH, Koh W, Kim HH, Lee YS. Standardized step-by-step technique using surgical landmarks in robotic lateral pelvic lymph node dissection. Ann Coloproctol. 2021; 37(1):58–60. DOI: 10.3393/ac.2020.08.05. PMID: 32972093. PMCID: PMC7989559.

9. Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics. 2020; 52(11):549–557. DOI: 10.1152/physiolgenomics.00089.2020. PMID: 32991251. PMCID: PMC7686876.

10. Rottoli M, Gori A, Pellino G, Flacco ME, Martellucci C, Spinelli A, et al. Colorectal cancer stage at diagnosis before vs during the COVID-19 pandemic in Italy. JAMA Netw Open. 2022; 5(11):e2243119.

11. Morris EJA, Goldacre R, Spata E, Mafham M, Finan PJ, Shelton J, et al. Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. Lancet Gastroenterol Hepatol. 2021; 6(3):199–208. DOI: 10.1016/S2468-1253(21)00005-4. PMID: 33453763.

12. Manlubatan SIT, Lopez MPJ, Onglao MAS, Monroy Iii HJ. Modifications to treatment plan of rectal cancer in response to COVID-19 at the Philippine general hospital. Ann Coloproctol. 2021; 37(4):225–231. DOI: 10.3393/ac.2021.00381.0054. PMID: 34364319. PMCID: PMC8391047.

13. Choi JY, Park IJ, Lee HG, Cho E, Kim YI, Kim CW, et al. Impact of the COVID-19 pandemic on surgical treatment patterns for colorectal cancer in a tertiary medical facility in Korea. Cancers. 2021; 13(9):2221. DOI: 10.3390/cancers13092221. PMID: 34066390. PMCID: PMC8125443.

14. Whittaker TM, Abdelrazek MEG, Fitzpatrick AJ, Froud JLJ, Kelly JR, Williamson JS, et al. Delay to elective colorectal cancer surgery and implications for survival: a systematic review and meta-analysis. Colorectal Dis. 2021; 23(7):1699–1711. DOI: 10.1111/codi.15625. PMID: 33714235. PMCID: PMC8251304.

15. Mukherji R, Marshall JL. Lessons learned in managing patients with colorectal cancer during the COVID-19 pandemic. Curr Treat Options Oncol. 2021; 22(10):93. DOI: 10.1007/s11864-021-00888-3. PMID: 34424418. PMCID: PMC8381863.

16. Rydbeck D, Bock D, Haglind E, Angenete E, Onerup A. Survival in relation to time to start of curative treatment of colon cancer: a national register-based observational noninferiority study. Colorectal Dis. 2023; 25(8):1613–1621. DOI: 10.1111/codi.16638. PMID: 37317006.

17. Shaukat A, Church T. Colorectal cancer screening in the USA in the wake of COVID-19. Lancet Gastroenterol Hepatol. 2020; 5(8):726–727. DOI: 10.1016/S2468-1253(20)30191-6. PMID: 32569576.

18. Health Insurance Review and Assessment Service [HIRA]. National interest medical procedures (examinations/surgeries, etc.) statistics [Internet]. Wonju (KR): HIRA;c2010. [cited 2023 Aug 10]. Available from: https://www.hira.or.kr.

19. Mason SE, Scott AJ, Markar SR, Clarke JM, Martin G, Winter Beatty J, et al. Insights from a global snapshot of the change in elective colorectal practice due to the COVID-19 pandemic. PLoS One. 2020; 15(10):e0240397. DOI: 10.1371/journal.pone.0240397. PMID: 33031464. PMCID: PMC7544024.

20. Meijer J, Elferink MAG, Van Hoeve JC, Buijsen J, Van Erning F, Nagtegaal ID, et al. Impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands: a population-based study. Clin Colorectal Cancer. 2022; 21(3):e171–e178. DOI: 10.1016/j.clcc.2022.02.005. PMID: 35346605. PMCID: PMC8890796.

21. Eklöv K, Nygren J, Bringman S, Löfgren J, Sjövall A, Nordenvall C, et al. Trends in treatment of colorectal cancer and short-term outcomes during the first wave of the COVID-19 pandemic in Sweden. JAMA Netw Open. 2022; 5(5):e2211065. DOI: 10.1001/jamanetworkopen.2022.11065. PMID: 35532933. PMCID: PMC9086839.

22. Eklöv K, Nygren J, Bringman S, Löfgren J, Sjövall A, Nordenvall C, et al. Colon cancer treatment in Sweden during the COVID-19 pandemic: a nationwide register-based study. Colorectal Dis. 2022; 24(8):925–932. DOI: 10.1111/codi.16129. PMID: 35362199. PMCID: PMC9111816.

23. Clifford RE, Harji D, Poynter L, Jackson R, Adams R, Fearnhead NS, et al. Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study. Br J Surg. 2021; 108(11):1270–1273. DOI: 10.1093/bjs/znab129. PMID: 33961013. PMCID: PMC8136009.

24. Forse CL, Petkiewicz S, Teo I, Purgina B, Klaric KA, Ramsay T, et al. Negative impact of COVID-19 associated health system shutdown on patients diagnosed with colorectal cancer: a retrospective study from a large tertiary center in Ontario, Canada. J Can Assoc Gastroenterol. 2021; 5(3):137–142. DOI: 10.1093/jcag/gwab044. PMID: 35664369. PMCID: PMC8754725.

25. Miyo M, Mizushima T, Nishimura J, Hata T, Tei M, Miyake Y, et al. Impact of the COVID-19 pandemic on colorectal cancer surgery in Japan: clinical study group of Osaka University-a multicenter retrospective study. Ann Gastroenterol Surg. 2022; 7(1):121–130. DOI: 10.1002/ags3.12616. PMID: 36247513. PMCID: PMC9538119.

26. Freund MR, Kent I, Horesh N, Smith T, Zamis M, Meyer R, et al. The effect of the first year of the COVID-19 pandemic on sphincter preserving surgery for rectal cancer: a single referral center experience. Surgery. 2022; 171(5):1209–1214. DOI: 10.1016/j.surg.2022.02.006. PMID: 35337683. PMCID: PMC8849841.

27. Rottoli M, Pellino G, Spinelli A, Flacco ME, Manzoli L, Morino M, et al. Impact of COVID-19 on the oncological outcomes of colorectal cancer surgery in northern Italy in 2019 and 2020: multicentre comparative cohort study. BJS Open. 2022; 6(1):zrab139. DOI: 10.1101/2021.04.19.21255730.

28. Chen MZ, Tay YK, Teoh WM, Kong JC, Carne P, D'Souza B, et al. Melbourne colorectal collaboration: a multicentre review of the impact of COVID-19 on colorectal cancer in Melbourne, Australia. ANZ J Surg. 2022; 92(5):1110–1116. DOI: 10.1111/ans.17603. PMID: 35393720. PMCID: PMC9111459.

29. Tarta C, Marian M, Capitanio M, Faur FI, Duta C, Diaconescu R, et al. The challenges of colorectal cancer surgery during the COVID-19 pandemic in Romania: a three-year retrospective study. Int J Environ Res Public Health. 2022; 19(21):14320. DOI: 10.3390/ijerph192114320. PMID: 36361200. PMCID: PMC9658781.

30. Ghosh S, Nevins EJ, Hicks GJ, Carney K, Emmett C, Mills SJ. Colorectal cancer care in the COVID-19 era: outcomes from a 'mixed site' model. Ann R Coll Surg Engl. 2022; 104(4):261–268.

31. Tang G, Pi F, Tao J, Wei Z. Impact of the COVID-19 pandemic on surgical outcomes in patients undergoing colorectal cancer surgery: a retrospective study and meta-analysis of data from 11,082 participants. Front Public Health. 2022; 10:907571. DOI: 10.3389/fpubh.2022.907571. PMID: 36249184. PMCID: PMC9556652.

32. COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020; 396(10243):27–38. DOI: 10.1016/S0140-6736(20)31182-X. PMID: 32479829.

33. Pirozzi BM, Siragusa L, Baldini G, Pellicciaro M, Grande M, Efrati C, et al. Influence of COVID-19 pandemic on colorectal cancer presentation, management and outcome during the COVID-19 pandemic. J Clin Med. 2023; 12(4):1425. DOI: 10.3390/jcm12041425. PMID: 36835958. PMCID: PMC9962694.

34. Cano-Valderrama O, Sánchez-Santos R, Vigorita V, Paniagua M, Flores E, Garrido L, et al. Has the COVID-19 pandemic changed the clinical picture and tumour stage at the time of presentation of patients with colorectal cancer? A retrospective cohort study. Cir Esp. 2023; 101(2):90–96. DOI: 10.1016/j.ciresp.2022.02.001. PMCID: PMC8831139.

35. Uyan M, Özdemir A, Kalcan S, Tomas K, Demiral G, Pergel A, et al. Effects of COVID-19 pandemic on colorectal cancer surgery. Sao Paulo Med J. 2022; 140(2):244–249. DOI: 10.1590/1516-3180.2021.0357.r1.30062021. PMID: 34586288. PMCID: PMC9610251.

36. Kiss BI, Sala TD, Török Á, Dénes MI, Borz CO, Popescu GA, et al. The impact of the COVID-19 pandemic on colorectal cancer patients in a tertiary center in Romania. Single center retrospective study. Chirurgia. 2022; 117(1):45–54. DOI: 10.21614/chirurgia.2611. PMID: 35272754.

37. Williams E, Kong JC, Singh P, Prabhakaran S, Warrier SK, Bell S. The impact of the COVID-19 pandemic on colorectal cancer diagnosis and management: a binational colorectal cancer audit study. ANZ J Surg. 2021; 91(10):2091–2096. DOI: 10.1111/ans.17071. PMID: 34235835.

38. Lee T, Cheng DZ, Foo FJ, Sivarajah SS, Ho LML, Aw D, et al. Did the COVID-19 lockdown result in a delay of colorectal cancer presentation and outcomes? A single centre review. Langenbecks Arch Surg. 2022; 407(2):739–745. DOI: 10.1007/s00423-022-02448-1. PMID: 35080644. PMCID: PMC8790546.

39. Lim JH, Lee WY, Yun SH, Kim HC, Cho YB, Huh JW, et al. Has the COVID-19 pandemic caused upshifting in colorectal cancer stage? Ann Coloproctol. 2021; 37(4):253–258. DOI: 10.3393/ac.2021.00269.0038. PMID: 34376026. PMCID: PMC8391042.

40. Kuryba A, Boyle JM, Blake HA, Aggarwal A, van der Meulen J, Braun M, et al. Surgical treatment and outcomes of colorectal cancer patients during the COVID-19 pandemic: a national population-based study in England. Ann Surg Open. 2021; 2(2):e071. DOI: 10.1097/AS9.0000000000000071. PMID: 34240077. PMCID: PMC8223908.

41. Tampo MMT, Onglao MAS, Lopez MPJ, Sacdalan MDP, Cruz MCL, Apellido RT, et al. Improved outcomes with implementation of an enhanced recovery after surgery pathway for patients undergoing elective colorectal surgery in the Philippines. Ann Coloproctol. 2022; 38(2):109–116. DOI: 10.3393/ac.2020.09.02. PMID: 32972103. PMCID: PMC9021849.

42. Koh W, Lee CS, Bae JH, Al-Sawat A, Lee IK, Jin HY. Clinical validation of implementing enhanced recovery after surgery protocol in elderly colorectal cancer patients. Ann Coloproctol. 2022; 38(1):47–52. DOI: 10.3393/ac.2021.00283.0040. PMID: 34284558. PMCID: PMC8898633.

43. Toh JWT, Cecire J, Hitos K, Shedden K, Gavegan F, Pathmanathan N, et al. The impact of variations in care and complications within a colorectal enhanced recovery after surgery program on length of stay. Ann Coloproctol. 2022; 38(1):36–46. DOI: 10.3393/ac.2020.11.23. PMID: 33957036. PMCID: PMC8898630.

44. Kudou M, Yamauchi M, Yamazato Y, Nishida T, Sogawa A, Yamamoto Y, et al. Minimally invasive surgery for colorectal cancer during the COVID-19 pandemic in a tertiary medical facility in Japan. In Vivo. 2022; 36(6):2806–2812. DOI: 10.21873/invivo.13018. PMID: 36309368. PMCID: PMC9677775.

45. Radulovic RS, Cuk VV, Juloski JT, Arbutina DD, Krdžic ID, Milic LV, et al. Is colorectal cancer stage affected by COVID-19 pandemic? Chirurgia. 2021; 116(3):331–338. DOI: 10.21614/chirurgia.116.3.331. PMID: 34191714.

46. Nasir IUI, Shah MF, Panteleimonitis S, Figueiredo N, Parvaiz A. Spotlight on laparoscopy in the surgical resection of locally advanced rectal cancer: multicenter propensity score match study. Ann Coloproctol. 2022; 38(4):307–313. DOI: 10.3393/ac.2020.01060.0151. PMID: 34399445. PMCID: PMC9441543.

47. Varela C, Kim NK. Surgical treatment of low-lying rectal cancer: updates. Ann Coloproctol. 2021; 37(6):395–424. DOI: 10.3393/ac.2021.00927.0132. PMID: 34961303. PMCID: PMC8717072.

48. Ng JY, Chen CC. Transanal total mesorectal excision for rectal cancer: it's come a long way and here to stay. Ann Coloproctol. 2022; 38(4):283–289. DOI: 10.3393/ac.2022.00374.0053. PMID: 36059075. PMCID: PMC9441544.

49. Piozzi GN, Kim SH. Robotic intersphincteric resection for low rectal cancer: technical controversies and a systematic review on the perioperative, oncological, and functional outcomes. Ann Coloproctol. 2021; 37(6):351–367. DOI: 10.3393/ac.2021.00836.0119. PMID: 34784706. PMCID: PMC8717069.

50. Lee TH, Choo JM, Kim JS, Shin SH, Kim JS, Baek SJ, et al. Characteristics and outcomes of colorectal cancer surgery by age in a tertiary center in Korea: a retrospective review. Ann Coloproctol. 2022; 38(3):244–252. DOI: 10.3393/ac.2021.00619.0088. PMID: 34735759. PMCID: PMC9263304.